Consumerlab on garlic
This article was originally published in The Tan Sheet
Executive Summary
Allicin yield in garlic preparations can vary by as much as 1,500%, Consumerlab.com study of 14 garlic supplements finds. Online testing firm rated products based on their ability to generate allicin, the chemical most commonly associated with efficacy in non-aged garlic. Allicin yield ranged between 400 mcg and 6,500 mcg among the 13 non-aged garlic products reviewed; firm used 3,600 mcg allicin per gram of garlic as the baseline amount for therapeutic benefit - a standard met by 11 of 14 products tested. Separately, Consumerlab has begun retesting all supplement categories reviewed since 1999. First category to be re-evaluated will be ginkgo biloba, which will include testing of huperzine A - a supplement ingredient marketed for memory enhancement...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.